Bra tattoo changed woman's life after breast cancer

A 69-year-old breast cancer survivor gets her confidence back after having a bra tattoo.
Source: BBC News | Health | UK Edition - Category: Consumer Health News Source Type: news

Related Links:

(American Association for Cancer Research) Six factors were associated with invasive recurrence of breast cancer after a diagnosis of ductal carcinoma in situ (DCIS), according to data from a meta-analysis.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
Publication date: Available online 24 April 2019Source: Journal of Organometallic ChemistryAuthor(s): Serap Şahin-Bölükbaşı, Neslihan ŞahinAbstractThe aim of this study was to present the synthesis, characterization and anticancer activities of two novel benzimidazole-based NHC salts (1a-b) and their silver(I) complexes (2a-b) with methylbenzyl and isopropylbenzyl chains. All compounds were prepared using Schlenk techniques in an inert atmosphere. The carbene complexes were prepared with the interaction of carbene precursors and Ag2O. All new compounds were characterized by elemental analysis, LC-MS, FT-IR, 1...
Source: Journal of Organometallic Chemistry - Category: Chemistry Source Type: research
ConclusionArtifact reduction in BT using a novel reconstruction method enables qualitatively and quantitatively improved clinical use of BT when metal artifacts can be a limiting factor such as in tomosynthesis-guided biopsy.
Source: European Journal of Radiology - Category: Radiology Source Type: research
Artem Sokolov1, Stephanie Ashenden2,3, Nil Sahin4,5, Richard Lewis2, Nurdan Erdem4, Elif Ozaltan4, Andreas Bender2, Frederick P. Roth5,6,7 and Murat Cokol1,4,5,8* 1Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, United States 2Centre for Molecular Informatics, Department of Chemistry, University of Cambridge, Cambridge, United Kingdom 3Discovery Sciences, IMed Biotech Unit, AstraZeneca R&D, Cambridge, United Kingdom 4Faculty of Engineering and Natural Sciences, Sabancı University, Istanbul, Turkey 5Donnelly Centre, University of Toronto, Toronto, ON, Canada 6Department of Molecular Gene...
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
In this study, we firstly tested the effects of QJSB on leucopenia using mice induced by cyclophosphamide. Our results suggested that QJSB significantly raised the number of peripheral white blood cells, platelets and nucleated bone marrow cells. Additionally, it markedly enhanced the cell viability and promoted the colony formation of bone marrow mononuclear cells. Furthermore, it reversed the serum cytokines IL-6 and G-CSF disorders. Then, using transcriptomics datasets and metabonomic datasets, we integrated transcriptomics-based network pharmacology and metabolomics technologies to investigate the mechanism of action o...
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
Karin Meissner1,2*, Nicola Talsky1, Elisabeth Olliges1,2, Carmen Jacob1,3,4, Oliver J. Stötzer5, Christoph Salat5, Michael Braun6 and Raluca Flondor1 1Institute of Medical Psychology, Faculty of Medicine, LMU Munich, Munich, Germany 2Division of Health Promotion, Coburg University of Applied Sciences, Coburg, Germany 3Clinical Neurosciences, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom 4Wessex Neurological Centre, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom 5Haematology and Oncology, Outpatient Cancer Ca...
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
The authors would like to note the replacement of Fig.  2b, for which Fig. 2a was placed erringly, with appropriate Fig. 2b.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research
AbstractPurpose of the ReviewBreast lesions of uncertain malignant potential (B3) are a heterogeneous group of diagnostic entities that can be associated with atypia. These are associated with in situ or invasive malignancy in 20 –30% of cases. The management of those lesions has been both controversial and challenging for the multidisciplinary teams.Recent FindingsThis is an up-to-date review of the current International Consensus on the management of B3 lesions with emphasis on the practical considerations.SummaryThrough multidisciplinary management pathways, the vast majority of B3 lesions should be managed by vac...
Source: Current Breast Cancer Reports - Category: Cancer & Oncology Source Type: research
AbstractPurpose of ReviewBreast cancer treatment has evolved through continuous integration of technological advances and changes in our understanding of tumor biology. Radical mastectomy was the best operation for the technology and beliefs of its time. Advances in technology, the acknowledgement that care is best delivered through a multi-modal approach, and continued investigation have resulted in less disfiguring procedures. Ablative therapy for the treatment of breast cancer is the natural continuation of this trend.Recent FindingsData from breast cancer ablation trials utilizing various energy forms have been favorab...
Source: Current Breast Cancer Reports - Category: Cancer & Oncology Source Type: research
Qingbin Cui1,2, Chao-Yun Cai2, Hai-Ling Gao2,3, Liang Ren1, Ning Ji2,4, Pranav Gupta2, Yuqi Yang2, Suneet Shukla5, Suresh V. Ambudkar5, Dong-Hua Yang2 and Zhe-Sheng Chen2* 1School of Public Health, Guangzhou Medical University, Guangdong, China 2Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY, United States 3Department of Histology and Embryology, Clinical Medical College, Weifang Medical University, Weifang, China 4Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tian...
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Health